Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L. Sos, Roman K. Thomas, Stefanie Fischer et al.|Proceedings of the National Academy of Sciences|2009Cited by 255
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agentsChristy C. Ong, Klaus P. Hoeflich|Breast Cancer Research|2015Cited by 74
Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibitionDonald S. Kirkpatrick, Klaus P. Hoeflich|Proceedings of the National Academy of Sciences|2013Cited by 56
The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Cancer Discovery|2024Cited by 43
Regulation of ERK3/MAPK6 expression by BRAFKlaus P. Hoeflich, Somasekar Seshagiri|International Journal of Oncology|2006Cited by 32